Return to program book search

Session Information

FRM F113 - Recent Advances in Treatment of Pigmentary Disorders

Open admission to eligible categories, no tuition or ticket

Subject:

Date: Monday, March 24

CME Credits: 2.00

Location: Room 102/104/106

Time: 10:00 AM - 12:00 PM

Director: Rebat M. Halder, MD, FAAD

Speakers:
  • Andrew F. Alexis, MD, FAAD
  • Iltefat H. Hamzavi, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Assess the effectiveness of recently developed treatments for pigmentary disorders.
  • Choose effective new treatments for patients with pigmentary disorders.

Description:
Dyspigmentation in the form of either hyperpigmentation, hypopigmentation or depigmentation is often psychologically devastating. Despite being common, pigmentary disorders remain difficult to treat. There have been a number of recent advances that are much more effective in treating vitiligo such as grafting, melanocyte transplantation and new modulators of phototherapy. Disorders of hyperpigmentation, such as postinflammatory hyperpigmentation and melasma are being treated with new topical agents such as licorice, rucinol, mulberry and ellagic acid. These disorders of hyperpigmentation can now be treated with lasers such as Q-switched Nd:YAG and fractional photothermolysis, and also with intense pulsed light.

Schedule:

Monday, March 24
10:00 AMWhy Are Pigmentary Disorders Difficult to Treat? / Dr. Halder
10:10 AMNew Topical Agents for Treating Disorders of Hyperpigmentation / Dr. Halder
10:30 AMLasers and Other Light Sources for Treating Disorders of Hyperpigmentation / Dr. Alexis
10:50 AMNew Modulators of Phototherapy for Vitiligo / Dr. Hamzavi
11:05 AMMixed Melanocyte/Keratinocyte Culture Transplants for Vitiligo / Dr. Hamzavi
11:25 AMSuction Blister Grafting for Vitiligo / Dr. Halder
11:45 AMQuestions and Answers / All faculty